Igor-Silva

Igor-Silva

Hi, today we are going to talk about McDermott International and its current landscape. McDermott International is poised to receive increasing attention from the market as relevant events are taking place. The company has struggled to keep good performance of its shares, despite the Freeport LNG project, that boosted McDermott shares after the first export...

Igor-Silva

Hi, today we are going to talk about PolyOne and its current landscape. PolyOne is poised to receive increasing attention from the market as relevant events are taking place. The global provider of specialized polymer materials and services issued better than expected EPS on its fourth-quarter and unveiled that will acquire a plastic-pigments unit from...

Igor-Silva

Hi, today we are going to talk about Axonics Modulation Technologies and its current landscape. Axonics Modulation is poised to receive increasing attention from the market as relevant events are taking place. The medical technology company announced that it received permission for nine patents related to its implantable sacral neuromodulation technology, which...

Igor-Silva

Hi, today we are going to talk about Facebook and its current landscape. Facebook is poised to receive increasing attention from the market as relevant events are taking place. After a series of polemics, Facebook has been making a strong endeavor to clean up its public image and try to regain public trust, on the game awards this year Facebook sponsored about...

Igor-Silva

Hi, today we are going to talk about FMC Corp and its current landscape. FMC Corp is poised to receive increasing attention from the market as relevant events are taking place. The American chemical manufacturing company announced that in Jun 2020 will replace its CEO Pierre Brondeau for Mark Douglas that has been serving as president and COO since Jun 2018, the...

Igor-Silva

Hi, today we are going to talk about Bed Bath & Beyond and its current landscape. Bed Bath & Beyond is poised to receive increasing attention from the market as relevant events are taking place. The American chain of domestic merchandise retail stores announced that it is going to start a major restructuring, as six senior leaders are leaving the company. At...

Igor-Silva

Hi, today we are going to talk about BGC Partners and its current landscape. BGC Partners is poised to receive increasing attention from the market as relevant events are taking place. The American global financial services company unveiled that is lowering its outlook for the quarter ending in Dec.31, forecasted back in October, justifying lower volumes on the...

Igor-Silva

Hi, today we are going to talk about MetLife and its current landscape. MetLife is poised to receive increasing attention from the market as relevant events are taking place. The Metropolitan Life Insurance Company agreed to pay a $10 million SEC fine for had broken federal securities laws related to books, records, and internal accounting controls. The company...

Igor-Silva

Hi, today we are going to talk about Green Dot Corp and its current landscape. Green Dot is poised to receive increasing attention from the market as relevant events are taking place. The American financial technology and bank holding company unveiled that its Founder and CEO Steven W. is leaving the company and the board to retire, Streit only will keep its role...

Igor-Silva

Hi, today we are going to talk about General Electric and its current landscape. General Electric is poised to receive increasing attention from the market as relevant events are taking place. Despite the good of year of the companies, some mixed events can shift the balance of sentiments; on the concerning side, GE might make a significant blow from the Boeing...

Igor-Silva

Hi, today we are going to talk about Epizyme and its current landscape. Epizyme is poised to receive increasing attention from the market as relevant events are taking place. The clinical-stage biopharmaceutical company received unanimous approval from the FDA for its cancer drug Tazemetostat for the treatment of patients with epithelioid sarcoma. Amid the...

Igor-Silva

Hi, today we are going to talk about YayYo and its current landscape. YayYo is poised to receive increasing attention from the market as relevant events are taking place. The tech company has established a partnership with LMP Automotive, which facilitated that YayYo was able to expand to Dallas, Texas a lucrative market that can boost YayYo for the next...

Igor-Silva

Hi, today we are going to talk about the Akorn and its current landscape. Akorn is poised to receive increasing attention from the market as relevant events are taking place. The American generic pharmaceuticals manufacturer has been crushed after analysts had called out the possibility of the company fill for bankruptcy. Akorn hasn't managed to generate much...

Igor-Silva

Hi, today we are going to talk about the Uniti Group and its current landscape. Uniti Group is poised to receive increasing attention from the market as relevant events are taking place. The company is looking to raise $85 million to acquire the Australian company 1300 Holdings, move that Uniti Group chairman believes to be assertive as would improve company data...

Igor-Silva

Hi, today we are going to talk about Noble Corp and its current landscape. Noble Corp is poised to receive increasing attention from the market as relevant events are taking place. The offshore drilling contractor named the industry veteran Stephen Butz as its new CFO, Butz previously was CFO at Rowan and Hercules Offshore and can represent a great change for the...

Igor-Silva

Hi, today we are going to talk about Vertex Pharmaceuticals and its current landscape. Vertex Pharmaceuticals is poised to receive increasing attention from the market as relevant events are taking place after Proteostasis Therapeutics had unveiled "positive" data from a phase 2 clinical trial testing its triple-drug combination in patients with cystic fibrosis,...

Igor-Silva

Hi, today we are going to talk about Immunogen and its current landscape. Immunogen is poised to receive increasing attention from the market after the announcement that it will start new trials based on an FDA advice that a new single-arm study in ovarian cancer could support accelerated approval for Mirvetuximab Soravtansine. We must remember that statistics...

Igor-Silva

Hi, today we are going to talk about the 22nd Century Group and its current landscape. 22nd Century Group is poised to receive increasing attention from the market as relevant events are taking place. The company has been under rumors that the FDA permitted the sale of two new low-nicotine cigarettes for sale to the public, as this new product can improve the...